Journal
Journal of Medicinal Chemistry
Publication Date
8-24-2023
Volume
66
Issue
16
First Page
11056
Last Page
11077
Document Type
Open Access Publication
DOI
10.1021/acs.jmedchem.3c00358
Rights and Permissions
Sarkar S, Mayer Bridwell AE, Good JAD, Wang ER, McKee SR, Valenta J, Harrison GA, Flentie KN, Henry FL, Wixe T, Demirel P, Vagolu SK, Chatagnon J, Machelart A, Brodin P, Tønjum T, Stallings CL, Almqvist F. Design, Synthesis, and Evaluation of Novel Δ2-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant Mycobacterium tuberculosis Mutant. J Med Chem. 2023 Aug 24;66(16):11056-11077. doi: 10.1021/acs.jmedchem.3c00358. Epub 2023 Jul 24.Copyright © 2023 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0.
Recommended Citation
Sarkar, Souvik; Mayer Bridwell, Anne E.; Wang, Erin R.; McKee, Samuel R.; Valenta, Joy; Harrison, Gregory A.; Flentie, Kelly N.; Henry, Frederick L.; Stallings, Christina L.; and et al., "Design, synthesis, and evaluation of novel Δ2‑thiazolino2‑pyridone derivatives that potentiate isoniazid activity in an isoniazid-resistant Mycobacterium tuberculosis mutant." Journal of Medicinal Chemistry. 66, 16. 11056 - 11077. (2023).
https://digitalcommons.wustl.edu/oa_4/2366
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
